In contrast, CD4+ T cell RNA-seq analysis revealed the specific expansion of cluster 2 in all 4 patients with cancer following anti–CTLA-4 and anti–PD-1 combination therapy, which corresponded to the time at which autoreactive B cells accumulated in the periphery (Figure 5, A and B). Here, CTLA4 is linked to cancer.